Profile data is unavailable for this security.
About the company
Innova Captab Ltd is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.
- Revenue in INR (TTM)10.81bn
- Net income in INR943.45m
- Incorporated2005
- Employees--
- LocationInnova Captab LtdSco-301, 2nd floor,Sector-9,PANCHKULA 134109IndiaIND
- Phone+91 1 724194500
- Websitehttp://www.innovacaptab.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 20.75bn | 1.10k | 41.61 | 3.87 | 25.70 | 2.92 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
| Hester Biosciences Ltd | 3.05bn | 188.89m | 20.97bn | 693.00 | 99.06 | 7.19 | 54.71 | 6.89 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| Amrutanjan Health Care Ltd | 4.21bn | 449.73m | 22.59bn | 575.00 | 50.42 | 7.83 | 44.28 | 5.36 | 15.51 | 15.51 | 145.00 | 99.85 | 1.16 | 7.34 | 10.41 | -- | 12.34 | 16.22 | 15.09 | 20.12 | 49.71 | 53.30 | 10.68 | 13.23 | 3.82 | 291.99 | 0.006 | 23.37 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
| Solara Active Pharma Sciences Ltd | 13.26bn | -5.67bn | 24.34bn | 2.36k | -- | 2.45 | -- | 1.84 | -145.25 | -145.25 | 339.41 | 239.08 | 0.505 | 1.75 | 2.99 | -- | -21.60 | -2.44 | -39.08 | -3.84 | 39.28 | 43.38 | -42.77 | -4.49 | 0.3549 | -1.89 | 0.5192 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| IOL Chemicals and Pharmaceuticals Ltd. | 21.33bn | 1.34bn | 25.08bn | 2.56k | 18.65 | 1.56 | 12.71 | 1.18 | 22.90 | 22.90 | 363.33 | 274.49 | 0.9998 | 3.72 | 4.37 | -- | 6.30 | 14.91 | 8.27 | 19.45 | 34.50 | 34.79 | 6.30 | 12.00 | 1.24 | 10.41 | 0.0199 | -- | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
| Dishman Carbogen Amcis Ltd | 26.16bn | -1.53bn | 26.58bn | 1.30k | -- | 0.4723 | 16.88 | 1.02 | -9.79 | -9.79 | 166.66 | 358.94 | 0.2748 | 0.7081 | 4.98 | -- | -1.61 | -0.3986 | -2.09 | -0.4888 | 77.17 | 74.89 | -5.87 | -1.54 | 0.4092 | -0.1265 | 0.2913 | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| RPG Life Sciences Limited | 5.82bn | 876.60m | 26.81bn | 1.27k | 30.59 | 7.15 | 25.60 | 4.61 | 53.00 | 53.00 | 351.92 | 226.65 | 1.25 | 1.88 | 13.45 | 4,583,071.00 | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 62.99 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 27.41bn | 1.23k | -- | 86.70 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Innova Captab Ltd | 10.81bn | 943.45m | 28.90bn | -- | 22.73 | 3.48 | 26.20 | 2.67 | 22.21 | 22.21 | 235.31 | 145.20 | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 32.64 | 25.18 | 8.73 | 8.04 | 1.64 | 6.45 | 0.2278 | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Morepen Laboratories Ltd | 16.90bn | 961.60m | 29.07bn | 1.65k | 30.25 | 3.43 | 22.35 | 1.72 | 1.88 | 1.88 | 33.11 | 16.58 | 1.41 | 4.45 | 5.74 | -- | 8.04 | 7.90 | 11.50 | 13.34 | 37.15 | 33.65 | 5.72 | 5.49 | 1.59 | 33.73 | 0.0331 | -- | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| SeQuent Scientific Ltd | 13.70bn | -358.69m | 31.18bn | 478.00 | -- | 4.75 | 97.67 | 2.28 | -1.45 | -1.45 | 56.27 | 26.37 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 31.78bn | 6.10k | 32.78 | 2.86 | 16.83 | 1.75 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Supriya Lifescience Ltd | 5.70bn | 1.19bn | 32.22bn | 392.00 | 27.05 | 3.95 | 23.88 | 5.65 | 14.80 | 14.80 | 70.87 | 101.31 | 0.655 | 2.21 | 5.81 | -- | 13.68 | 19.08 | 15.19 | 24.04 | 61.12 | 58.71 | 20.88 | 24.71 | 4.06 | 66.40 | 0.0067 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Gufic BioSciences Ltd | 8.07bn | 861.36m | 35.79bn | 1.63k | 40.79 | 6.72 | 34.70 | 4.44 | 8.75 | 8.75 | 81.90 | 53.11 | 0.8258 | 2.03 | 3.01 | -- | 8.82 | 11.46 | 13.32 | 19.21 | 51.67 | 46.99 | 10.68 | 10.46 | 1.08 | 8.37 | 0.3847 | -- | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
Data as of Jul 03 2024. Currency figures normalised to Innova Captab Ltd's reporting currency: Indian Rupee INR
14.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kotak Mahindra Asset Management Co. Ltd.as of 31 May 2024 | 2.29m | 4.00% |
| Canara Robeco Asset Management Co. Ltd.as of 15 Jun 2024 | 2.11m | 3.69% |
| Invesco Asset Management (India) Pvt Ltd.as of 31 May 2024 | 1.42m | 2.47% |
| SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Apr 2024 | 1.32m | 2.31% |
| WhiteOak Capital Asset Management Ltd.as of 31 May 2024 | 689.32k | 1.21% |
| Bandhan Asset Management Co. Ltd.as of 31 May 2024 | 324.97k | 0.57% |
| Edelweiss Asset Management Ltd.as of 31 May 2024 | 233.41k | 0.41% |
| Aditya Birla Sun Life Insurance Co. Ltd.as of 31 May 2024 | 3.28k | 0.01% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 May 2024 | 146.00 | 0.00% |
More ▼
Data from 30 Apr 2024 - 15 Jun 2024Source: FactSet Research Systems Inc.
